Renal DialysisKidney Failure, ChronicHemodialysis Units, HospitalKidney TransplantationCapital ExpendituresDithioerythritolKidney DiseasesKidneyPeritoneal DialysisGraft RejectionGraft SurvivalImmunosuppressive AgentsDiabetic NephropathiesGlomerular Filtration RateDialysisCreatinineRetrospective StudiesTreatment OutcomeWAGR SyndromePeritoneal Dialysis, Continuous AmbulatoryRisk FactorsTime FactorsDialysis SolutionsRenal Insufficiency, ChronicTissue DonorsUremiaTacrolimusFollow-Up StudiesLiving DonorsProspective StudiesTransplantation, HomologousMycophenolic AcidWaiting ListsCyclosporineTransplantationCohort StudiesKidney Function TestsCadaverTissue and Organ ProcurementBiological MarkersGenes, Wilms TumorDelayed Graft FunctionTransplantsDisease ProgressionWilms TumorBK VirusRisk AssessmentUnited StatesKidney TubulesImmunosuppressionPancreas TransplantationAcute Kidney InjuryPrevalenceProteinuriaPolyomavirus InfectionsPostoperative ComplicationsRenal Replacement TherapyRenal InsufficiencyHistocompatibility TestingNephrologyDirected Tissue DonationKidney GlomerulusBiopsyHeart TransplantationIsoantibodiesSurvival RateIncidenceAntilymphocyte SerumPeritonitisGlomerulonephritisProportional Hazards ModelsChronic DiseaseIranNephrectomyKidney CortexPeritoneumPrognosisLung TransplantationIntensive Care UnitsCytomegalovirus InfectionsDonor SelectionSurvival AnalysisHLA AntigensPolycystic Kidney DiseasesGlomerulosclerosis, Focal SegmentalRegistriesCalcineurinImmunocompromised HostKidney NeoplasmsPrimary Graft DysfunctionSirolimusMultivariate AnalysisComplement C4bKaplan-Meier EstimateDrug Therapy, CombinationAge FactorsNephritis, InterstitialCardiovascular DiseasesTransplantation ImmunologyCatheters, Indwelling